Menu
Not yet recruiting NCT07025616

Effects of Buteyko Breathing Exercise in Children With Uncontrolled Asthma

No phase Interventional Breathing Techniques Asthma Control Level Asthma in Children Asthma Patients

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Buteyko, Asthma reliever and controller.
Who it may be relevant to
Registry conditions: Breathing Techniques, Asthma Control Level, Asthma in Children, Asthma Patients. Basic parameters: 7 years — 17 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Indonesia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Effectiveness of Buteyko Breathing Exercise in Children With Uncontrolled Asthma: A Single Blind, Randomized Controlled Trial

Overview

This randomized controlled trial study aimed to measure the effectiveness of the combination of 4-weeks Buteyko breathing exercises and pharmacological therapy compared with pharmacological therapy alone in children with uncontrolled asthma.

Interventions

  • Behavioral Buteyko
    The Buteyko breathing exercise is a method that encourages nasal breathing, reducing breathing volume, and using breath-holding exercises to normalize breathing pattern
  • Drug Asthma reliever and controller
    Asthma reliever and controller according to GINA (Global Initiative for Asthma) guideline

Primary outcome measures

  • Asthma control [Time frame: At enrollment and end of fourth-week]
Secondary outcome measures (7)
  • Asthma Quality of Life [Time frame: At enrollment and end of fourth-week]
  • Bronchodilator use [Time frame: At end of fourth-week]
  • FEV1 [Time frame: At enrollment and end of fourth-week]
  • FVC [Time frame: At enrollment and end of fourth-week]
  • FEV1/FVC [Time frame: At enrollment and end of fourth-week]
  • PEFR [Time frame: At enrollment and end of fourth-week]
  • Control Pause [Time frame: At enrollment and end of fourth-week]

Eligibility criteria

Inclusion criteria

  • Children aged 7-17 years
  • Uncontrolled or partially controlled asthma (GINA Symptom Control Tool score > 1)
  • Receive bronchodilator therapy, either oral or inhaler from a pediatrician.
  • Children and parents/care givers agree to participate in the study until the end, and parents/care givers sign the informed consent form.
  • Can understand instructions.

Exclusion criteria

  • Inpatients
  • Have received Buteyko breathing exercises or other breathing exercises.
  • Have congenital heart disease, pneumonia, or other significant and uncontrolled health disorders.
  • Have severe physical disabilities or mental retardation that could potentially prevent the implementation of Buteyko breathing exercises.
  • Have contraindications for spirometry examination

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Indonesia · 1 center
  • Universitas Indonesia, Faculty of Medicine — Jakarta Pusat

Identifiers

NCT: NCT07025616 · 24-07-1177

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗